139 related articles for article (PubMed ID: 22345569)
21. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.
Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH
Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790
[TBL] [Abstract][Full Text] [Related]
22. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
Dye BK; Butler C; Lincoln J
J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
[TBL] [Abstract][Full Text] [Related]
23. Morphological and biochemical investigations of mitral valve endocardiosis in pigs.
Castagnaro M; Amedeo S; Bertolotto A; Manzardo E; Riccio A; Guarda F
Res Vet Sci; 1997; 62(2):121-5. PubMed ID: 9243709
[TBL] [Abstract][Full Text] [Related]
24. Myxomatous mitral valve chordae. II: Selective elevation of glycosaminoglycan content.
Grande-Allen KJ; Griffin BP; Calabro A; Ratliff NB; Cosgrove DM; Vesely I
J Heart Valve Dis; 2001 May; 10(3):325-32; discussion 332-3. PubMed ID: 11380095
[TBL] [Abstract][Full Text] [Related]
25. Differential cell-matrix responses in hypoxia-stimulated aortic versus mitral valves.
Sapp MC; Krishnamurthy VK; Puperi DS; Bhatnagar S; Fatora G; Mutyala N; Grande-Allen KJ
J R Soc Interface; 2016 Dec; 13(125):. PubMed ID: 28003526
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclic mechanical strain on glycosaminoglycan and proteoglycan synthesis by heart valve cells.
Gupta V; Tseng H; Lawrence BD; Grande-Allen KJ
Acta Biomater; 2009 Feb; 5(2):531-40. PubMed ID: 19004676
[TBL] [Abstract][Full Text] [Related]
27. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
28. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study.
Grande-Allen KJ; Borowski AG; Troughton RW; Houghtaling PL; Dipaola NR; Moravec CS; Vesely I; Griffin BP
J Am Coll Cardiol; 2005 Jan; 45(1):54-61. PubMed ID: 15629373
[TBL] [Abstract][Full Text] [Related]
29. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.
Cremer SE; Moesgaard SG; Rasmussen CE; Zois NE; Falk T; Reimann MJ; Cirera S; Aupperle H; Oyama MA; Olsen LH
Res Vet Sci; 2015 Jun; 100():197-206. PubMed ID: 25843893
[TBL] [Abstract][Full Text] [Related]
30. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration.
Barth PJ; Köster H; Moosdorf R
Pathol Res Pract; 2005; 201(4):301-4. PubMed ID: 15991836
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia promotes primitive glycosaminoglycan-rich extracellular matrix composition in developing heart valves.
Amofa D; Hulin A; Nakada Y; Sadek HA; Yutzey KE
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1143-H1154. PubMed ID: 28842437
[TBL] [Abstract][Full Text] [Related]
33. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-mediated regulation of the secretory properties of mitral valve interstitial cells.
Salhiyyah K; Sarathchandra P; Latif N; Yacoub MH; Chester AH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H14-H23. PubMed ID: 28314761
[TBL] [Abstract][Full Text] [Related]
35. Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture.
Waxman AS; Kornreich BG; Gould RA; Moïse NS; Butcher JT
J Vet Cardiol; 2012 Mar; 14(1):211-21. PubMed ID: 22386586
[TBL] [Abstract][Full Text] [Related]
36. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease.
Han RI; Black A; Culshaw GJ; French AT; Else RW; Corcoran BM
Am J Vet Res; 2008 Jun; 69(6):763-9. PubMed ID: 18518656
[TBL] [Abstract][Full Text] [Related]
37. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve.
Stephens EH; Chu CK; Grande-Allen KJ
Acta Biomater; 2008 Sep; 4(5):1148-60. PubMed ID: 18448399
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Serotonin-Regulated Calcific Processes in Aortic and Mitral Valvular Interstitial Cells.
Wang X; Deb N; Lacerda CMR
ACS Omega; 2021 Aug; 6(30):19494-19505. PubMed ID: 34368536
[TBL] [Abstract][Full Text] [Related]
39. Reversible secretion of glycosaminoglycans and proteoglycans by cyclically stretched valvular cells in 3D culture.
Gupta V; Werdenberg JA; Lawrence BD; Mendez JS; Stephens EH; Grande-Allen KJ
Ann Biomed Eng; 2008 Jul; 36(7):1092-103. PubMed ID: 18425579
[TBL] [Abstract][Full Text] [Related]
40. Signaling pathways in mitral valve degeneration.
Orton EC; Lacerda CM; MacLea HB
J Vet Cardiol; 2012 Mar; 14(1):7-17. PubMed ID: 22364692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
